Westfield Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-297,550
Closed -$13.5M 251
2023
Q3
$13.5M Buy
+297,550
New +$13.5M 0.09% 172